Tag Archives: Brighton Park Capital

Indegene Acquires Medical Marketing Economics (MME)

Indegene has acquired market-access advisory Medical Marketing Economics (MME) for $10 million, as it seeks to bolster its biopharma pricing and reimbursement capabilities